Other Clinical Trial - S.M.A.R.T.® Nitinol Self-Expandable Stent in

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Superficial Femoral Artery Disease

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT04546477` - Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease	N/A
	Completed	`NCT01230229` - Primary Stenting vs Conservative Treatment in Claudicants - a Study on Quality of Life	N/A

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT04546477 - Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease

N/A

Completed

NCT01230229 - Primary Stenting vs Conservative Treatment in Claudicants - a Study on Quality of Life

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00739102
Study type	Interventional
Source	Cordis Corporation
Contact
Status	Completed
Phase	N/A
Start date	August 2008
Completion date	April 2013

S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease — STROLL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms